Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +187.9% | +64.9% | 2 / 3 | +5.6% | -0.20 pp | +16.74 pp | +13.9% | 0.24 | 10.88 | 361 | +5,6% | 99,8 | +168,4% | 10.88 | 12.03 | −9,5% |
| Pts | 12 | 12 | 8 | 0 | 4 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 30.200 (close price on 2026-10-19)EPS (TTM): 2.775
Financial charts
1.Revenue & growth
VND bn361Q2/26
1.Revenue & growth
VND bn361Q2/26
2.Profit & growth
VND bn95,2Q2/26
3.Profit mix (Penman)
VND bn389Q2/26
4.Margins & cost structure
%36.7%Q2/26
5.Returns & cash cycle
% · days11.9%Q2/26
6.Earnings quality & cash
VND bn512Q2/26
7.Asset structure
VND bn3.512Q2/26
8.Funding & debt health
VND bn · times3.512Q2/26
9.Revenue backlog
VND bn13,9Q2/26
10.Valuation
times · %10,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %794Q2/26
Adjusted EPS growth, latest quarter
188%
Average adjusted EPS growth, 3 quarters
65.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26